Naohiko Hayakawa - Concepedia

Author

Naohiko Hayakawa

Chugai Pharma (United States)

Also Known As

N. Hayakawa, Naohiko HAYAKAWA, Naohiko Hayakawa

Publications

747

Citations

H-Index

Concepts

All Affiliations

Chugai Pharma (United States)Jikei University School of Medicine Nagasaki University

About

Naohiko Hayakawa is an author at Chugai Pharma (United States) specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	320
2	Engineering	2	2	70
3	Health Sciences	1	1	16
4	Social Sciences	1	1	11
5	Biomedical Engineering	1	1	50

Naohiko Hayakawa

Publications

700

Citations

H-Index

Page 1

	Year	Citations
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17 Misato Hashizume, Naohiko Hayakawa, Masahiko Mihara Lara D. Veeken	2008	351
IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system Misato Hashizume, Naohiko Hayakawa, Miho Suzuki, Rheumatology International InflammationCytokineAngiogenesisImmunologyTnf-α Induced Angiogenesis	2009	84
Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model Mitsuru Saito, Ayako Shiraishi, Masako Ito, Bone Regenerative MedicineTissue EngineeringBone HealthEngineeringMechanical Properties	2009	50
Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production Yasushi Uchiyama, Hiroto Yoshida, Nobuo Koike, International Immunopharmacology InflammationCytokineBlood Il-6 LevelAutoimmune DiseaseImmune Regulation	2008	48
Effects of Alfacalcidol on Mechanical Properties and Collagen Cross-Links of the Femoral Diaphysis in Glucocorticoid-Treated Rats Mitsuru Saito, Keishi Marumo, Chikara Ushiku, Calcified Tissue International MechanobiologyEngineeringMechanical PropertiesOrthopaedic SurgeryMedicine	2011	20
In Vivo Dose-related Receptor Binding of the Vitamin D Analogue [<sup>3</sup>H]-1,25-dihydroxy-22-oxavitamin D<sub>3</sub> (OCT) in Rat Parathyroid, Kidney Distal and Proximal Tubules, Duodenum, and Skin, Studied by Quantitative Receptor Autoradiography Nobuo Koike, Naohiko Hayakawa, Kenji Kumaki, Journal of Histochemistry & Cytochemistry Parathyroid DiseaseParathyroid GlandExperimental PharmacologyOxidative StressMolecular Pharmacology	1998	19
Salivary glands epithelial and myoepithelial cells are major vitamin D targets Walter E. Stumpf, Naohiko Hayakawa European Journal of Drug Metabolism and Pharmacokinetics PathogenesisImmunologyOral BiologySalivary GlandsPathology	2007	19
Isolation and Characterization of Human Monoclonal Autoantibodies to Glutamic Acid Decarboxylase Naohiko Hayakawa, Lakdasa Premawardhana, M. Powell, Autoimmunity	2002	17
1,25-Dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification Walter E. Stumpf, Nobuo Koike, Naohiko Hayakawa, Histochemistry and Cell Biology Bone DiseaseOrthopaedic Surgery1,25-Dihydroxyvitamin D3PhysiologyIntramembranous Ossification	1994	16
Distribution of 1,25-dihydroxyvitamin D3[22-oxa] in vivo receptor binding in adult and developing skin Walter E. Stumpf, Nobuo Koike, Naohiko Hayakawa, Archives of Dermatological Research MedicinePhysiologyVivo Receptor BindingDermatologyPharmacology	1995	15

Page 1